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erentia[[y infected the kidney. Development of re- 
nal candidiasis was accompanied by a substantial 
decrease of MIF (day 0: 37.5+4.2pg/g; day 9: 
19=l=4.7pg/g, P =0.002), IFN? (day 0: 5.9=1=1.4 ng/g; 
day 9: 3.5=l=1.4ng/g, P=0.002), IL-12 (day 0: 
43.4=l=6.7ng/g; day 9: 19.6=l=11.8ng/g, P=0.009), 
and IL-10 (day 0: 8.3+2.7ng/g; day 9:3.8+3 ng/g, 
P =0.06) concentrations in the kidney. Neutraliza- 
tion of MIF activity with anti-MIF IgG decreased 
the pro-inflammatory response in the kidney, as 
shown by a reduction of IL-12/IL-10 (P =0.002) and 
of IFN?/IL-10 (P=0.001) ratios at day 5. Moreover, 
treatment of mice with anti-MIF IgG markedly in- 
creased mortality of invasive candidiasis (from 40% 
in control IgG treated mice to 73% in anti-MIF IgG 
treated mice, P=0.02). 
Conclusion: Neutralizing MIF activity impairs the 
host pro-inflammatory innate immune response and 
augment lethality of invasive candidiasis. Thus, 
these data identify MIF as an important effec- 
tor molecule of the host innate immune defenses 
against Candida infection. 
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Background: PG is a complex macromo[ecu[e com- 
posed of g[ycan chains to which stem peptides 
are attached. It is reputed to trigger cytokine 
release (eg TNF) from macrophages and other re- 
sponsive ceils. Recently we showed that PG from 
S. pneumoniae (Sp) contained inactive mono- and 
dimeric stem peptides and inflammatory trimeric 
stem peptides. However, trimeric stem peptides 
purified from S. aureus (Sa) were inactive. These 
were cross[inked via 5 g[ycines whereas those in 
Sp were cross[inked directly or only via 2 a[anines. 
The difference in the length of the stem peptide 
cross[ink in these species might explain the diver- 
gence of their inflammatory activity. This hypothe- 
sis was tested with stem peptides purified from Sa 
FEM mutants with different sized cross[inks. 
Methods: Lipoteichoic acid-free PG was purified 
from Sp 8: Sa (cross[ink via 1, 3 or 5 g[yines), so[ubi[- 
ised by auto[ysins and separated by HPLC. Mono-, 
di- and trimeric stem peptides were identified by 
mass spectrometry. Stimu[atory activity was tested 
by incubating them with human blood in triplicate 
for 8h at 37°C + po[ymixin (pmx) on 3 separate 
days. TNF released was quantified by bioassay. 
Results: Insoluble PG from Sa~tSp induced TNF 
(1000 pg/m[) at 10ug/m[. Mono- and dimeric stem 
peptides from both species were inactive at this 
concentration. Trimers purified from Sa mutants 
cross[inked via 1, 3 or 5 g[ycines were also inactive, 
whereas trimers from Sp were active at 0.1 ug/m[. 
Pmx did not inhibit this activation. 
Conclusions: Inflammatory activity of the insolu- 
ble PG and inactivity of their isolated mono- and 
dipeptides suggest that a minimum po[ymerisation 
of the stem peptides is required for activation. 
The po[ymerisation must yield a structure of spe- 
cific size and conformation to be active. Active 
trimers from Sp had such an optimum conformation 
whereas those of the Sa mutants with different 
cross[inks were inactive. Inflammatory activity of 
PG stem peptides is thus structure specific. It de- 
pends on their po[ymerisation, nature and compo- 
sition of their cross[ink. 
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Background: The cytokine macrophage migration 
inhibitory factor (MIF) is an important regulator 
of innate immunity, inflammation and oncogenesis. 
MIF promoter po[ymorphisms have been associated 
with susceptibility to and/or severity of rheuma- 
toid arthritis, atopia and ulcerative colitis. Yet, the 
molecular mechanisms regulating the expression of 
the MIF gene remain largely unknown. 
Objective: To elucidate the transcriptional and 
post-transcriptional regulation of MIF. 
Methods: Experiments were performed with hu- 
man PBMCs, THP-1 monocytic ceils, HeLa and A549 
epithelial ceils and HaCat keratinocytes, murine 
macrophages and insect Sf9 ceils. MIF mRNA, pro- 
tein and promoter activities were assessed by 
Northern blotting, Western blotting and [uciferase 
reporter assay, respectively. Transcription factor 
binding activity was assessed by EMSA, supershift 
and chromatin immunoprecipitation (CHIP). Ge- 
nomic DNA methy[ation was assessed by sodium 
bisu[fite sequencing. 
Results: Several potential regulatory sequences 
were identified within a 2.8 kb fragment upstream 
of the transcription start site. Spl and CRE binding 
sites in the proximal MIF promoter were required 
for fuji MIF promoter activity. EMSA, supershifts 
and ChIP analyses showed that Spl and CREB tran- 
scription factors bound to the proximal Spl and 
$48 International Journal o[ In[ectious Diseases (2006) 10($1 ) Abstracts 
CRE sites in vitro and in vivo. Mithramycin A, a 
competitive inhibitor of Spl binding to DNA, re- 
duced MIF promoter activity and mRNA levels in 
THP-1 ceils, whereas expression of Spl in Spl- 
deficient Sf9 insect ceils increased promoter activ- 
ity. Albeit located in a CpG island, MIF expression 
was not modulated by DNA methy[ation of its CpG 
sites. Steady state MIF mRNA levels correlated with 
mRNA haft-lives in HeLa, A549, HaCat and THP-1 
ceils suggesting that mRNA stability is a key deter- 
minant of ceil-specific post-transcriptional control 
of MIF expression. 
Conclusions: The present findings provide evidence 
imp[icating Spl and CREB and mRNA stabi[ity in 
transcriptional and post-transcriptional regulation 
of human MIF gene expression. The identification 
of the factors involved in the regulation of the 
constitutive MIF gene expression may provide im- 
portant insights into the molecular mechanisms 
leading to increased MIF expression in cancer and 
in inflammatory and auto-immune diseases. 
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Background: Histone deacety[ases (HDACs) are 
regulators of chromatin structure and gene expres- 
sion. Originally investigated as anticancer drugs, 
HDAC inhibitors (HDI) have emerged to be potent 
anti-inflammatory agents for auto-immune, allergic 
and inflammatory diseases. 
Objective: To investigate the effects of tri- 
chostatin A (TSA), a prototypica[ HDI, on pro- 
inflammatory cytokine expression by innate im- 
mune ceils exposed to microbial products. 
Methods: Mouse RAW 264.7, peritoneal and bone 
marrow-derived macrophages and dendritic ceils 
(DCs) and human whole blood were pre-incubated 
for 1 h with TSA (0-0.1 ~M) before stimulation with 
LPS, Pam3CSK4, peptidog[ycan, CpG DNA or heat- 
ki[[ed E. coli, S. aureus or C. albicans. Cytokine 
mRNA and protein expression were measured by 
Northern Noting and by ELISA. MHC II, CD40, CD80 
and CD86 expression by DCs was analyzed by flow 
cytometry. NF-kB activity was assessed by EMSA 
and transient transfection of RAW ceils with a kB- 
[uciferase reporter vector. Cytokine production was 
also measured 1 h after i.v. challenge with LPS 
(4~g/kg) and TSA (800~g/kg) in D-ga[actosamine- 
sensitized mice. 
Results: TSA was a potent inhibitor of TNF, IL-6 
and IL-12 production (up to 100% at 0.1 ~M TSA) 
by mouse macrophages, DCs and/or whole blood in 
response to a[[ microbial stimuli. TSA also strongly 
inhibited CD40 and CD86 up-regulation by DCs 
stimulated with LPS and Pam3CSK4. Inhibition of 
LPS and Pam3CSK4 induced TNF release by TSA- 
treated RAW 264.7 macrophages was associated 
with: (1) >75% inhibition of TNF mRNA levels, 
(2) reduced nuclear trans[ocation of NF-kB, and 
(3) marked inhibition (10-fold) of NF-kB-mediated 
transcriptional activity. In vivo, administration of 
TSA resulted in a striking inhibition (>90%, P =0.02) 
of LPS-induced IL-6 release. 
Conclusions: HDAC inhibitors exhibit profound in- 
hibitory effects on innate immune gene expres- 
sion by macrophages and dendritic ceils exposed 
to microbial products. These results suggest that 
HDI might be a new class of immunomodu[ators 
that deserve further investigation as anti-sepsis 
agents. Yet, these observations also suggest that 
HDI might impair innate immune defenses and thus 
predispose cancer patients who are treated with 
these agents to severe infections. 
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Down-regulates Macrophage Migration Factor 
(MIF) Expression 
T. Roger*, X. Ding, D. Le Roy, A-L. Chanson, 
T. Ca[andra. In[ectious Diseases Service, CHUV, 
Lausanne, Switzerland 
Background: Increased expression or activity of 
histone deacety[ases (HDACs) have been detected 
in cancer ceils, which strengthened development 
of pharmacological inhibitors of HDACs (HDIs). HDIs 
were observed to induce the differentiation and 
the apoptosis of tumor ceils in vitro, so that several 
of these drugs are currently being tested as anti- 
cancer agents in clinical trials. Yet, the molecular 
basis of the anti-tumoral effects of HDIs is not 
fully understood. Macrophage migration inhibitory 
factor (MIF), a pro-inflammatory cytokine, has re- 
cently been implicated in ceil proliferation, angio- 
genesis and oncogenesis and may therefore repre- 
sent a novel target of HDI action. 
Objective: To study whether HDIs modify the ex- 
pression of MIF in human ceils. 
Methods: Human whole blood, HeLa cervix epithe- 
lial ceils, HaCat keratinocytes and U-937, KGla and 
HL-60 leukemic ceil lines were exposed to tricho- 
statin A (TSA), a prototypica[ HDI. MIF gene tran- 
scription, mRNA, protein and fuji-length, truncated 
or mutated promoter activities were assessed by 
